OUR MISSION

ANS Biotech is an independent preclinical CRO exclusively dedicated to the in vivo pharmacology of pain.

Founded by scientists from the pharmaceutical industry, ANS Biotech offers its clients a unique combination of exceptional expertise in the fundamentals of pain pharmacology as well as a proven record of R&D program management for new and innovative analgesics.

Our mission is to support the drug discovery efforts of companies involved in human and animal health, food and nutrition, by offering a broad range of consulting services and a growing list of clinically relevant disease and efficacy models.

As a close Pharma and Biotech partner, ANS Biotech commits itself to providing cost-effective preclinical pharmacology services performed to the highest ethical and quality standards. Our customized scientific studies can help to establish proof of concept & mechanism of action for drug candidates and achieve the critically important positioning of these agents within precise therapeutic categories (neuropathic, bone/joint, visceral, postoperative pain…).

YOUR EXPECTATIONS

An interactive, collaborative relationship in pain research

Extensive expertise and scientific advice

Robust tools for selection of innovative analgesics

Best in class standard or customized services

Reliable and predictible models and tests

AS YOUR SCIENTIFIC PARTNER, WE COMMIT TO PROVIDING YOU WITH:

Extensive expertise (scientific advice, project management) for successful research and development of innovative analgesics with an emphasis on unmet medical needs.

Preclinical Pain Profiling with a relevant selection of products and services to meet your needs and expectations.

Best in class in vivo pharmacology services carried out by highly skilled scientists in behavioral pharmacology.

Customized fee-for-service (FFS) or flexible full-time-equivalent (FTE) models and scientific collaborations meeting your drug discovery and development objectives

Studies run in accordance with IASP (International Association for the Study of Pain) ethics recommendations

Studies run in compliance with the in-house Quality Management Program with reference to ISO 9001 and GLP norms requirements.

Access to clinical pharmacology capabilities in pain research (Clinical Investigation Center CIC).